Ocuphire Pharma, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Equipment, Net

Equipment, Net

9 Months Ended

Sep. 30, 2011

7.	Equipment, Net

	September 30, 2011			December 31, 2010

Furniture and fixtures	$	32,646		$	32,169
Office equipment		80,120			77,032
Lab and computer equipment		430,261			429,415
Leasehold improvements		110,713			110,713

Total fixed assets		653,740			649,329
Less: Accumulated depreciation		(560,668	)		(525,764	)

Net carrying amount	$	93,072		$	123,565

Depreciation expense was $10,127 and $11,663 for the three months ended September 30, 2011 and 2010, respectively, and $34,904, and $34,843 for the nine months ended September 30, 2011 and 2010, respectively.

- Definition

The entire disclosure for long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software. This disclosure may include property plant and equipment accounting policies and methodology, a schedule of property, plant and equipment gross, additions, deletions, transfers and other changes, depreciation, depletion and amortization expense, net, accumulated depreciation, depletion and amortization expense and useful lives, income statement disclosures, assets held for sale and public utility disclosures.

+ References + Details